Implementation of Neonatal Screening Program for Congenital Hypothyroidism in Eastern Morocco
International Journal of Neonatal Screening · 17.07.2025 · 11 (3) · 55
DOI: 10.3390/ijns11030055 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 17.07.2025. Verfasst von Fatima Wahoud und 5 weiteren Autor:innen. Beteiligte Einrichtung: Maternal Child and Mental Health Research Laboratory, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University, Oujda 60049, Morocco. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Congenital hypothyroidism (CH) is one of the major preventable causes of intellectual disability. This study evaluates the incidence of CH through a newborn screening (NBS) program in eastern Morocco. A descriptive cross-sectional design was used and heel prick blood samples were collected on blotting paper to measure Thyroid-Stimulating Hormone (TSH) using an immunofluorimetric assay. 4062 newborns were screened (51.3% male, 48.7% female). TSH levels significantly varied by age: newborns sampled before 24 h had a higher median TSH (3.7 µU/mL [0.10–28.90]) compared to those sampled at 24 h or more (2.1 µU/mL [0.10–32.30]; p < 0.001). Using age-specific cut-off values, 18 suspected CH cases were recalled (recall rate: 0.44%). Among the 16 cases who completed confirmatory testing, 4 had transient hyperthyrotropinemia (HTT), characterized by mildly abnormal serum TSH and T4 levels that normalized spontaneously after few months without treatment. Three cases were diagnosed with CH confirmed at birth with markedly elevated serum TSH concentrations and significantly reduced T4 levels. Consequently, the birth prevalence of CH confirmed at birth was 1:1354 live births. The median preanalytical delay was 6 days (IQR: 3–12) and the TSH result turnaround was 8 days (IQR: 5–15), potentially affecting timely intervention. This first report from eastern Morocco confirms the relevance of neonatal screening but highlights delays that must be addressed to enhance early diagnosis and management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Maternal Child and Mental Health Research Laboratory, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University, Oujda 60049, Morocco.
- Higher Institute of Nursing Professions and Health Techniques, Oujda 60000, Morocco.
- Higher Institute of Nursing Professions and Health Techniques, Fez 30050, Morocco.
ORCID-Profile: Fatima Wahoud, Samia Essadki
Zitieren
APA
Wahoud, F., Essadki, S., Zirar, K., Lamsyah, R., Hajjaji, W., & Amrani, R. (2025). Implementation of Neonatal Screening Program for Congenital Hypothyroidism in Eastern Morocco. International Journal of Neonatal Screening, 11(3), 55. https://doi.org/10.3390/ijns11030055
Vancouver
Wahoud F, Essadki S, Zirar K, Lamsyah R, Hajjaji W, Amrani R. Implementation of Neonatal Screening Program for Congenital Hypothyroidism in Eastern Morocco. International Journal of Neonatal Screening. 2025;11(3):55. doi:10.3390/ijns11030055
BibTeX
@article{Wahoud2025,
author = {Wahoud, Fatima and Essadki, Samia and Zirar, Khadija and Lamsyah, Rajae and Hajjaji, Wissam and Amrani, Rim},
title = {Implementation of Neonatal Screening Program for Congenital Hypothyroidism in Eastern Morocco},
journal = {International Journal of Neonatal Screening},
year = {2025},
volume = {11},
number = {3},
pages = {55},
doi = {10.3390/ijns11030055}
}
EUVIMED